The Paxlovid pills are being developed at Pfizer’s two Irish plants in Ringaskiddy and Newbridge. Picture: Reuters
Pfizer’s new anti-viral drugs for Covid-19 will only be prescribed for “high-risk patients” for now, but may provide benefits to the wider public in time, according to the scientist who developed the treatment. Dr Annaliesa Anderson, the clinical development lead on the Paxlovid antiviral programme, was speaking to the Business Post from New Jersey in the US.Subscribe from just €1 for the first month!
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New bill may push more legal costs on those who take insurers to court | Business PostRobert Troy: ‘If someone wants to reject their award and bring it to court and the court doesn’t increase the award any further, well then, they're going to have to pay for that’ obraonain now this is a good thing and will help
Source: businessposthq - 🏆 8. / 71 Read more »
Ronan to make new play for Dublin portfolio after legal case dropped | Business PostDeveloper may be seeking a new partner to bid for three landmark properties after ongoing dispute with US group Fortress is resolved out of court
Source: businessposthq - 🏆 8. / 71 Read more »
ESB’s new gas power contracts triple in value | Business PostWhistleblower has accused semi-state of abusing market position and ‘lowballing’ offers in earlier auctions
Source: businessposthq - 🏆 8. / 71 Read more »